| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $19.4M | +37.8% |
| Cost of Revenue | $9.1M | +34.9% |
| Gross Profit | $10.3M | +40.4% |
| R&D Expense | $3.0M | +57.8% |
| SG&A Expense | $9.9M | +121.5% |
| Operating Income | -$11.5M | -138.0% |
| Interest Expense | $6.1M | +88.6% |
| Pre-tax Income | -$7.1M | -19.5% |
| Net Income | -$7.1M | -19.5% |
| EPS (Basic) | -$0.71 | +53.0% |
| EPS (Diluted) | -$0.71 | +53.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.9M | +960.7% |
| Accounts Receivable | $2.8M | +35.5% |
| Inventory | $640K | +69.0% |
| Current Assets | $21.2M | +414.9% |
| Total Assets | $33.2M | +334.6% |
| Current Liabilities | $7.1M | +7.9% |
| Long-term Debt | $245K | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$10.2M | -120.9% |
| Capital Expenditures | $1.4M | +349.3% |
| Investing Cash Flow | -$1.4M | -349.3% |
| Financing Cash Flow | $26.0M | +432.8% |
| Free Cash Flow | -$11.6M | -134.8% |
| Total Liabilities |
| $53.7M |
| +141.6% |
| Stockholders' Equity | -$20.5M | +61.5% |